1OT fundamentals
An in-depth look to OVID THERAPEUTICS DL-,001 operating, investing, and financing activities
1OT free cash flow for Q1 24 is -15.48 M EUR. For 2023, 1OT free cash flow was -41.51 M EUR and operating cash flow was -41.48 M EUR.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM